» Articles » PMID: 32118043

Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men

Overview
Date 2020 Mar 3
PMID 32118043
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is one of the most frequent cardiovascular diseases among both women and men. Although age-adjusted AF incidence and prevalence is larger among men, women are older at the time of AF diagnosis and have larger risk for AF-associated adverse outcomes such as morality and stroke. Based on evidence from epidemiological studies, elevated body mass index seems to confer a higher risk of AF among men. However, evidence regarding sex differences in the association between diabetes mellitus, elevated blood pressure, and dysglycemia with AF remains conflicting. While men with AF have larger burden of coronary artery disease, women with AF tend to have a larger prevalence of heart failure and valvular heart disease. Recently, several women-specific risk factors including pregnancy and its complications and number of children have been associated with AF. Earlier age at menopause, despite being a strong marker of adverse cardiometabolic risk, does not seem to be associated with increased risk of AF. To reduce the AF burden in both genders, better understanding of the differences between women and men with regard to AF is central. Large-scale studies are needed to separately investigate and report on women and men. Besides observations from epidemiological and clinical studies, to improve our understanding of sexual dimorphism in AF, sufficiently large genome-wide association studies as well as well-powered Mendelian randomization studies are essential to shed light on the sex-specific nature of the associations of risk factors with AF.

Citing Articles

Association of single and multiple cardiometabolic diseases with atrial fibrillation: a prospective cohort study.

Peng Q, Ma T, Gao M, Wang X, Pan W Open Heart. 2025; 12(1).

PMID: 39988343 PMC: 11848664. DOI: 10.1136/openhrt-2024-003034.


Cardiovascular health and risks of atrial fibrillation and its prognosis.

Lu Z, Ke J, Yang H, Zhang X, Wang Y, Hou Y Am J Prev Cardiol. 2025; 21():100915.

PMID: 39807446 PMC: 11728968. DOI: 10.1016/j.ajpc.2024.100915.


Sex differences in overweight and obese patients undergoing high-power short-duration pulmonary vein isolation for atrial fibrillation: an observational cohort study.

Weyand S, Adam V, Biehler P, Hagele P, Hanger S, Lobig S Sci Rep. 2024; 14(1):28053.

PMID: 39543134 PMC: 11564744. DOI: 10.1038/s41598-024-78730-7.


Effects of SZV-2649, a new multiple ion channel inhibitor mexiletine analogue.

Mohammed A, Naveed M, Szabados T, Szatmari I, Lorinczi B, Matyus P Sci Rep. 2024; 14(1):23188.

PMID: 39369049 PMC: 11455950. DOI: 10.1038/s41598-024-73576-5.


Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular-Kidney-Metabolic Factors: SIMETAP-AF Study.

Ruiz-Garcia A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Martinez E, Pallares-Carratala V Medicina (Kaunas). 2024; 60(8).

PMID: 39202590 PMC: 11356659. DOI: 10.3390/medicina60081309.


References
1.
Huxley R, Filion K, Konety S, Alonso A . Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol. 2011; 108(1):56-62. PMC: 3181495. DOI: 10.1016/j.amjcard.2011.03.004. View

2.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38):2893-2962. DOI: 10.1093/eurheartj/ehw210. View

3.
Linde C, Bongiorni M, Birgersdotter-Green U, Curtis A, Deisenhofer I, Furokawa T . Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace. 2018; 20(10):1565-1565ao. DOI: 10.1093/europace/euy067. View

4.
January C, Samuel Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland Jr J . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130(23):2071-104. DOI: 10.1161/CIR.0000000000000040. View

5.
Ko D, Rahman F, Schnabel R, Yin X, Benjamin E, Christophersen I . Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol. 2016; 13(6):321-32. PMC: 5579870. DOI: 10.1038/nrcardio.2016.45. View